Combination therapy in Kala-azar

J Assoc Physicians India. 1995 May;43(5):319-20.

Abstract

128 untreated cases of Kala-azar were divided in 4 equal groups of 32, Group A was treated with Sodium Stibogluconate (SSG) in the dose of 20 mg/kg/body wt. for 30 days. Group B was treated SSG plus allopurinol in the dose of 20 mg/kg/body wt. orally in divided dosage for 30 days. Group C received SSG plus Ketoconazole 600 mg orally in divided dosage for 30 days. Group D in addition to SSG also received levamisole in single oral daily dose of 13 mg/kg/body wt. for 30 days. Response of Group B, C and D was compared to Group A. Results from this study revealed combination of allopurinol with SSG to be statistically not superior to SSG alone.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Allopurinol / adverse effects
  • Allopurinol / therapeutic use
  • Antimony Sodium Gluconate / adverse effects
  • Antimony Sodium Gluconate / therapeutic use
  • Antiprotozoal Agents / adverse effects
  • Antiprotozoal Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Ketoconazole / adverse effects
  • Ketoconazole / therapeutic use
  • Leishmaniasis, Visceral / drug therapy*
  • Levamisole / adverse effects
  • Levamisole / therapeutic use
  • Male

Substances

  • Antiprotozoal Agents
  • Levamisole
  • Allopurinol
  • Ketoconazole
  • Antimony Sodium Gluconate